Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Intangibles (2016 - 2025)

Niagen Bioscience (NAGE) has disclosed Intangibles for 14 consecutive years, with $5.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Intangibles rose 1476.6% to $5.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.7 million, a 1476.6% increase, with the full-year FY2025 number at $5.7 million, up 1476.6% from a year prior.
  • Intangibles was $5.7 million for Q4 2025 at Niagen Bioscience, up from $246000.0 in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $5.7 million in Q4 2025 to a low of $246000.0 in Q3 2025.
  • A 5-year average of $849210.5 and a median of $591000.0 in 2023 define the central range for Intangibles.
  • Biggest YoY gain for Intangibles was 1476.6% in 2025; the steepest drop was 38.04% in 2025.
  • Niagen Bioscience's Intangibles stood at $857000.0 in 2021, then fell by 21.7% to $671000.0 in 2022, then dropped by 23.99% to $510000.0 in 2023, then fell by 29.61% to $359000.0 in 2024, then skyrocketed by 1476.6% to $5.7 million in 2025.
  • Per Business Quant, the three most recent readings for NAGE's Intangibles are $5.7 million (Q4 2025), $246000.0 (Q3 2025), and $284000.0 (Q2 2025).